Vanda Pharmaceuticals Inc... (VNDA)
undefined
undefined%
At close: undefined
4.64
1.08%
After-hours Dec 13, 2024, 05:18 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04
Net Income 2.51M 6.28M 33.15M 23.34M 115.55M 25.21M -15.57M -18.01M -39.87M 20.19M -20.25M -27.66M -9.80M 7.19M -35.86M -51.06M -74.07M -63.51M -23.88M -9.47M
Depreciation & Amortization 3.01M 2.73M 2.84M 2.86M 2.89M 2.96M 2.98M 11.87M 13.55M 2.78M 1.93M 2.13M 1.96M 1.83M 1.42M 530.80K 571.59K 575.37K 423.83K 376.71K
Stock-Based Compensation 14.04M 16.28M 15.37M 13.36M 13.46M 11.67M 10.46M 8.54M 7.96M 5.88M 4.60M 4.09M 5.50M 4.98M 11.23M 13.39M 19.62M 6.13B - -
Other Working Capital 11.71M -151.00K 4.40M 3.13M 761.00K 8.22M -7.44M -7.58M 32.32M -29.30M -26.79M -25.55M -26.36M -23.66M 196.05M -6.10M 3.57M -521.18M 686.46K 416.56K
Other Non-Cash Items -4.72M -507.00K 3.37M 1.71M -1.31M 167.00K 587.00K 708.00K 657.00K -77.62M 155.00K 1.83M 900.00K -2.70M 138.09K -235.16K 18.05M 5.75M 5.06M 66.08K
Deferred Income Tax -1.29M 1.13M 6.75M 6.19M -87.77M -2.22M -426.00K -104.00K 677.00K 174.00K - 560.00K 1.82M -1.82M - -174 -19.59M -6.13B - -
Change in Working Capital -747.00K 6.07M 2.74M 4.32M 3.13M -7.79M -26.00K -11.11M 29.46M -32.96M -26.02M -25.86M -28.79M -20.38M 192.40M -8.57M 3.78M 5.53M 686.46K 416.56K
Operating Cash Flow 12.80M 31.98M 64.21M 51.77M 45.95M 29.99M -1.98M -8.10M 12.45M -81.55M -39.59M -44.92M -28.41M -10.90M 169.34M -45.96M -51.64M -51.62M -17.71M -8.61M
Capital Expenditures -383.00K -679.00K -552.00K -1.79M -1.02M -25.37M -1.66M -1.41M -2.53M -8.77M -176.00K -2.02M -275.00K - -12.00M -943.66K -279.43K -1.35M -291.98K -414.53K
Acquisitions -100.67M -50.60M -12.00K -229.00K 67.29M 25.00M - - - -8.00M - - - - 12.00M - - - - -
Purchase of Investments -512.61M -349.26M -420.46M -346.62M -394.52M -282.39M -148.13M -165.41M -193.11M -93.34M -65.60M -60.87M -160.21M -202.44M -11.37M -14.79M -138.95M -102.23M -11.85M -
Sales Maturities Of Investments 601.60M 399.86M 344.32M 306.92M 327.23M 198.10M 139.57M 156.79M 169.04M 89.83M 31.50M 108.64M 234.84M 46.75M 18.63M 58.82M 90.27M 111.81M 1.75M -
Other Investing Acitivies - 50.60M 12.00K 229.00K -67.29M -25.00M 124.00K -46.00K -24.07M 8.24M -34.10M 47.77M -600.00K 66.00K -12.00M - 200.18K - -430.23K -
Investing Cash Flow -12.06M 49.92M -76.70M -41.50M -68.31M -109.66M -10.11M -10.07M -26.60M -12.04M -34.27M 45.75M 73.75M -155.62M -4.74M 43.09M -48.76M 8.22M -10.82M -414.53K
Debt Repayment - - - - - - - - - - - - - - - - - -142.61K -224.19K -199.33K
Common Stock Repurchased - - - - - - - - -283.00K - - - - - - - - - - -
Dividend Paid - - - - - - - - - - - - - - - - - - - -
Other Financial Acitivies - 734.00K 3.55M 5.63M 6.26M 6.26M 5.25M 7.75M 4.09M 2.42M 1.35M 12.00K 25.00K 3.78M 1.62M - 148.64K - - 18.35M
Financial Cash Flow - 734.00K 3.55M 5.63M 6.26M 107.13M 5.25M 7.75M 4.09M 89.73M 49.86M 12.00K 25.00K 3.78M 1.62M - 111.40M 53.31M 33.29M 18.15M
Net Cash Flow 792.00K 82.91M -9.02M 15.96M -16.10M 27.41M -6.80M -10.42M -10.06M -3.86M -24.01M 849.00K 45.36M -162.74M 166.22M -2.85M 11.00M 9.92M 4.75M 9.09M
Free Cash Flow 12.42M 31.30M 63.66M 49.98M 44.93M 4.62M -3.65M -9.51M 9.92M -90.32M -39.77M -46.93M -28.68M -10.90M 157.34M -46.90M -51.92M -52.97M -18.01M -9.03M